NetworkNewsBreaks – Noble Capital Markets, Inc. Announces Panel Discussion Set to Address the Next Generation of Innovative Immunotherapy Agents, Inflammasome Inhibitors
Noble Capital Markets today announced that it has assembled a panel of scientists and experienced life science executives to present a discussion titled “The Next Generation of Innovative Immunotherapy Agents, Inflammasome Inhibitors” at Noble’s 16th annual small and micro-cap investor conference. NobleCon16 is slated to take place at the new flagship Hard Rock Guitar Hotel in Fort Lauderdale, Florida on February 16-18, 2020. According to the update, co-founders, CEOs and leading-edge scientists of emerging growth companies in the inflammasome space, with venture capital firm representation, are included on the panel. “Bringing together a leading group of experts actively involved in…







